CN Bio raises $21 million to scale up organ-on-a-chip technology 23-Apr-2024 By Isabel Cameron CN Bio has raised $21 million in Series B financing to meet increasing demand for its organ-on-a-chip (OOC) solutions.
AnaBios acquires Cell Systems to expand cell portfolio 11-Apr-2023 By Ben Hargreaves Cell Systems is a human primary cell and cell culture media company, with the deal allowing AnaBios to expand its existing portfolio.
Emulate enhances tech aimed at supporting disease research and drug development 22-Nov-2021 By Jane Byrne Emulate, Inc recently launched the Zoë-CM2 Culture Module, a second-generation Zoë instrument core to its ‘Organ-on-a-Chip’ based Human Emulation System.